Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 88, Issue 1, 2003, Pages

  Gottstein, R ^a   Cooke, R W I ^a  

^a LIVERPOOL WOMEN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

BLOOD GROUP ABO INCOMPATIBILITY; CLINICAL TRIAL; CONFIDENCE INTERVAL; DOSE RESPONSE; EXCHANGE BLOOD TRANSFUSION; GESTATIONAL AGE; HEMOLYTIC ANEMIA; HOSPITALIZATION; HUMAN; HYPOCALCEMIA; HYPOGLYCEMIA; LENGTH OF STAY; NEWBORN; NEWBORN CARE; PHOTOTHERAPY; PRIORITY JOURNAL; REVIEW; RHESUS INCOMPATIBILITY; SIDE EFFECT; TREATMENT OUTCOME;

EID: 0037232854     PISSN: 00039888     EISSN: 13592998     Source Type: Journal    
DOI: 10.1136/fn.88.1.f6     Document Type: Review

References (28)

1. Imbach P, d'Apuzzo V, Hirt A, et al. High dose intravenous gammaglobulin for idiopathic thrombocytopenic purpuro in childhood. Lancet 1981;1:1228-31.
2. Bolton-Maggs PHB, Moon I. Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines. Lancet 1997;350:620-3.
3. Fehr J, Hofmann V, Kappeler U. Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin. N Engl J Med 1982;306:1254-18.
4. Wenkse G, Gaedicke G, Heyes H. Idiopathic thrombocytopaenic purpura in pregnancy and neonatal period. Blut 1984;48:377-82.
5. Bussel JB, Berkowitz RL, Lynch L, et al. Antenatal management of alloimmune thrombocytopenia with intravenous γ-globulin: a randomized trial of the addition of low-dose steroid to intravenous γ-globulin. Am J Obstet Gynecol 1996;174:1414-23.
6. Voto LS, Mathet ER, Zapaterio JL, et al. High-dose gammaglobulin (IVIG) followed by intrauterine transfusions (IUTs): a new alternative for the treatment of severe fetal hemolytic disease. J Perinat Med 1997;25:85-8.
7. Doreen MC, van-Kamp IL, Scherpenisse JW, et al. No beneficial effect of low-dose fetal intravenous gammaglobulin administration in combination with intravascular transfusions in severe Rh D haemolytic disease. Vox-Sang 1994;66:253-7.
8. Alonso JG, Decaro J, Marrero A, et al. Repeated direct fetal intravascular high-dose immunoglobulin therapy for the treatment of Rh hemolytic disease. J Perinat Med 1994;22:415-19.
9. Ouwehand WH, Smith G, Ranasinghe E. Management of severe alloimmune thrombocytopenia in the newborn. Arch Dis Child Fetal Neonatal Ed 2000;82:F173-5.
10. Ohlsson A, Lacy JB. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants. (Cochrane Review). The Cochrane Library Oxford: Update Software, 2000:issue 3.
11. Stanley TV, Grimwood K. Classical Kawasaki disease in a neonate. Arch Dis Child Fetal Neonatal Ed 2002;86:F135-6.
12. Chitkara U, Bussel J, Alvarez M, et al. High-dose intravenous gamma globulin: does it have a role in the treatment of severe erythroblastois fetalis? Obstet Gynecol 1990;76:703-8.
13. Urbaniak SJ. ADCC (K cell) lysis of human erythrocytes sensitized with Rhesus alloantibodies. II. Investigation into mechanism of lysis. Br J Haematal 1979;42:315-28.
14. Jadad AR, Rennie D. The randomised controlled trial gets a middle-aged checkup. JAMA 1998;279:319-20.
15. Alpay F, Sarici SÜ, Okutan V, et al. High-dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice. Acta Paediatr 1999;88:216-19.
16. Dagoglu T, Ovali F, Samaci N, et al. High-dose intravenous immunoglobulin therapy for rhesus haemolytic disease. J Int Med Res 1995;23:264-71.
17. Rübo J, Albrecht K, Lasch P, et al. High-dose introvenous immune-globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease. J Pediatr 1992;121:93-7.
18. Rübo J, Wahn V. Hochdosierte Immunglobulintherapie der Hyperbilirubinämie bei Rhesusinkompatibilität. Infusionsther Transfusionsmed 1993;20:104-9.
19. Voto LS, Sexer H, Ferreira G, et al. Neonatal administration of high-dose intravenous immunoglobulin in rhesus hemolytic disease. J Perinat Med 1995;23:443-51.
20. Rübo J, Wahn V, et al. Influence of high dosage immuno-globulin therapy on hyperbilirubinemia in rhesus hemolytic disease. A co-operative study. Monatsschr Kinderheilk 1996;144:516-19.
21. Oski FA, Naiman JL. Erythroblastosis fetalis. In: Oski FA, Naiman JL, eds. Haematological problems in the newborn. Philadelphia: WB Saunders Company, 1982:283-346.
22. Polácek K. Das universale Diagramm zur Behandlung der Hyperbilirubinämie der Neugeborenen. Pädiatrische Praxis 1984;29:1-3.
23. Haward H, Martlew V, McFayden I, et al. Consequences for fetus and neonate of maternal red cell allo-immunisation. Arch Dis Child Fetal Neonatal Ed 1998;78:F62-6.
24. Keenan W J, Kazmaier Novak K, Sutherland JM, et al. Morbidity and mortality associated with exchange transfusion. Pediatrics 1985;75:417-21
25. Healey CJ, Sabharwal NK, Daub J, et al. Outbreak of acute hepatitis C following the use of anti-hepatitis C virus-screened intravenous immunoglobulin therapy. Gastroenterology 1996;110:1120-6.
26. Yap PL. Intravenous immunoglobulin and hepatitis C virus: on overview of transmission episodes with emphasis on manufacturing data. Clin Ther 1996;18(suppl B):43-58.
27. Dunhem C, Dicato MA, Ries F. Side-effect of intravenous immune globulin. Clin Exp Immunol 1994;97(suppl 1):79-83.
28. Burks AW, Sampson HA, Buckley RH. Anaphylactic reactions after gammagloblin administration in patients with hypogommaglabulinaemia. Detection of IgE antibodies to IgA. N Engl J Med 1986;314:560-3.